Cypress Capital Management (Wyoming)’s Bristol-Myers Squibb BMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q3
Sell
-660
Closed -$30K 199
2019
Q2
$30K Sell
660
-736
-53% -$34.3K 0.04% 139
2019
Q1
$67K Sell
1,396
-164
-11% -$8.17K 0.09% 101
2018
Q4
$81K Sell
1,560
-350
-18% -$18.8K 0.16% 98
2018
Q3
$119K Buy
1,910
+1,160
+155% +$68.8K 0.12% 115
2018
Q2
$42K Sell
750
-250
-25% -$13.5K 0.04% 172
2018
Q1
$63K Sell
1,000
-350
-26% -$22.5K 0.07% 137
2017
Q4
$83K Sell
1,350
-1,920
-59% -$120K 0.09% 130
2017
Q3
$208K Hold
3,270
0.25% 77
2017
Q2
$182K Sell
3,270
-10,584
-76% -$576K 0.21% 72
2017
Q1
$753K Sell
13,854
-2,000
-13% -$110K 0.93% 22
2016
Q4
$938K Sell
15,854
-788
-5% -$43.1K 0.99% 21
2016
Q3
$897K Buy
16,642
+50
+0.3% +$3.21K 1.15% 21
2016
Q2
$1.22M Buy
16,592
+480
+3% +$33.9K 1.6% 15
2016
Q1
$1.03M Buy
16,112
+397
+3% +$25K 1.39% 17
2015
Q4
$1.08M Hold
15,715
1.36% 18
2015
Q3
$930K Sell
15,715
-1,442
-8% -$91.5K 1.19% 22
2015
Q2
$1.14M Sell
17,157
-300
-2% -$19.8K 1.29% 24
2015
Q1
$1.13M Sell
17,457
-200
-1% -$12.5K 1.38% 23
2014
Q4
$1.04M Buy
+17,657
New +$996K 1.35% 20

Other funds holding BMY

Cypress Capital Management (Wyoming)'s BMY Position: Q3 2019 in Review

Cypress Capital Management (Wyoming) sold out of Bristol-Myers Squibb (BMY) in Q3 2019, closing a stake of 660 shares — an estimated $30K sold.

Cypress Capital Management (Wyoming) first reported a position in BMY in Q4 2014 and held it in 19 quarters. The position peaked at $1.22M in Q2 2016. 1,813 funds tracked by Wall St. Rank hold BMY as of Q3 2019.

  • Cypress Capital Management (Wyoming) reported no remaining Bristol-Myers Squibb position as of Q3 2019 after selling out during the quarter.
  • Cypress Capital Management (Wyoming) sold 660 Bristol-Myers Squibb shares in Q3 2019, an estimated $30K.
  • Cypress Capital Management (Wyoming) first reported a position in Bristol-Myers Squibb in Q4 2014 and held it in 19 quarters.
  • Cypress Capital Management (Wyoming)'s Bristol-Myers Squibb position peaked at $1.22M in Q2 2016.
  • 1,813 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q3 2019.

Based on Cypress Capital Management (Wyoming)'s 13F filing for Q3 2019, filed 12 Nov 2019.